Craig D. Cairns Buys 1,200 Shares of Transcat, Inc. (NASDAQ:TRNS) Stock

Transcat, Inc. (NASDAQ:TRNS) Director Craig D. Cairns bought 1,200 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was purchased at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Transcat Stock Up 2.7 %

Shares of Transcat stock opened at $79.30 on Wednesday. Transcat, Inc. has a twelve month low of $73.37 and a twelve month high of $147.12. The company has a market cap of $729.56 million, a price-to-earnings ratio of 42.86 and a beta of 0.68. The company’s 50 day moving average is $101.93 and its 200 day moving average is $112.97.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.43%. During the same period in the prior year, the firm earned $0.56 EPS. Sell-side analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TRNS has been the topic of several analyst reports. Northland Securities reiterated a “market perform” rating and issued a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. HC Wainwright dropped their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, Craig Hallum increased their price objective on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, Transcat presently has an average rating of “Hold” and an average target price of $111.50.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Rice Hall James & Associates LLC raised its position in Transcat by 40.2% in the fourth quarter. Rice Hall James & Associates LLC now owns 35,685 shares of the scientific and technical instruments company’s stock worth $3,773,000 after acquiring an additional 10,238 shares during the period. Principal Financial Group Inc. raised its position in Transcat by 8.5% in the fourth quarter. Principal Financial Group Inc. now owns 5,002 shares of the scientific and technical instruments company’s stock worth $529,000 after acquiring an additional 391 shares during the period. Rhumbline Advisers increased its stake in shares of Transcat by 4.1% in the fourth quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company’s stock worth $1,306,000 after purchasing an additional 486 shares in the last quarter. Catawba River Capital increased its stake in shares of Transcat by 2.2% in the fourth quarter. Catawba River Capital now owns 67,300 shares of the scientific and technical instruments company’s stock worth $7,116,000 after purchasing an additional 1,473 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC increased its stake in shares of Transcat by 23.2% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 6,477 shares of the scientific and technical instruments company’s stock worth $685,000 after purchasing an additional 1,219 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.